Work

Supplementary Data from Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Figure S1; Supplementary Tables S1-S2.

DOI: 10.1158/1078-0432.22441947.v1

Authors: Philip C. Amrein, Eyal C. Attar, Tak Takvorian, Ephraim P. Hochberg, Karen K. Ballen, Kathleen M. Leahy, David C. Fisher, Ann S. LaCasce, Eric D. Jacobsen, Philippe Armand, Robert P. Hasserjian, Lillian Werner, Donna Neuberg, Jennifer R. Brown

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362426634

Cites:

Cited by:

Related to: 10